KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis
Oncolytic adenoviral therapy is a promising approach for pancreatic cancer treatment. However, the limited capacity of murine cells to produce infectious viral progeny precludes the full evaluation of the virotherapy in a suitable immunocompetent mouse model. Here, we report that the murine KPC-I ce...
Saved in:
Main Authors: | Marc Otero-Mateo, Francesc Estrany Jr, Sabrina Arcas-Márquez, Laura Moya-Borrego, Giancarlo Castellano, Miquel Castany, Ramon Alemany, Cristina Fillat |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Molecular Therapy: Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S295032992400170X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OFFICIAL MEDICATIONS FOR ANTI-TUMOR GENE THERAPY
by: E. R. Nemtsova, et al.
Published: (2016-12-01) -
Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
by: Peter S. Kim, et al.
Published: (2015-03-01) -
<i>In vitro</i> and <i>in vivo</i> tropism and biodistribution of recombinant simian adenovirus type 25
by: Irina V. Vavilova, et al.
Published: (2024-11-01) -
Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity
by: Tomoko Ohtani, et al.
Published: (2024-11-01) -
Canine adenovirus serotype 2 isolation and determination of its cultivation parameters
by: A. A. Klimova
Published: (2024-12-01)